Market Overview:
The global liposomal drug-delivery system market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for better and more efficient drug-delivery systems, rising prevalence of chronic diseases, and growing focus on nanotechnology. The global liposomal drug-delivery system market is segmented on the basis of type into liposome vitamin, liposome ceramide, liposome coenzyme Q10 (CoQ10), and others. The medical application segment is expected to account for the largest share of the global liposomal drug-delivery system market in 2018. This can be attributed to factors such as rising incidence of chronic diseases and increasing use of targeted therapies that require better delivery systems.
Product Definition:
Liposomes are lipid bilayers that can encapsulate drugs and other payloads. The use of liposomes as drug-delivery systems offers several advantages over traditional drug delivery methods, including increased stability and reduced toxicity. Liposomal drug-delivery systems can also improve the absorption of drugs into tissues, which may result in improved efficacy.
Liposome Vitamin:
Liposome is a lipoprotein particle that contains both hydrophobic and hydrophilic parts. It is formed by phospholipids, cholesterol, and fatty acids. The drug-containing particles are taken up by the cell via receptor-cell interactions; they then either get converted into an intracellularly acting drug or released extracellularly as a prodrug.
Liposome Ceramide:
Liposome is a lipoprotein structure composed of two phospholipid bilayers, which are separated by an interlinking protein. Ceramide is one of the major components in the lipid component of human skin. It helps to maintain moisture and enhances hydration from within as well as outside the cell. Liposomes are used for various applications such as drug delivery, gene therapy, cancer treatment and diagnosis among others.
Application Insights:
On the basis of application, the global liposomal drug-delivery system market is segmented into medical and cosmetics. The medical application dominated the overall market in terms of revenue in 2017. Increasing number of clinical trials with these systems as a drug delivery platform for various diseases such as diabetes, cancer, and cardiovascular disorders are contributing to their increasing use in medical applications.
The growing importance of targeted drug delivery has led to an increased focus on new research developments that can specifically deliver drugs at desired locations within cells or tissues. This has resulted in greater demand for liposomal formulations that can be used for targeted delivery within cells or across cell membranes. These types of formulations have been studied extensively over recent years owing to their ability to target specific organs while sparing other areas; this property makes them suitable for treating chronic conditions such as diabetes and cardiovascular disorders where there is a high risk of side effects due to widespread tissue damage caused by conventional methods used for delivering drugs (such as via injection).
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of players and increased R&D activities. The region is expected to maintain its dominance over the forecast period due to increasing product launches and technological advancements. For instance, in February 2018, Pfizer Inc. announced that it has completed phase 3 clinical trial for ceramide-based liposomal doxorubicin (Adriamycin) formulation for treatment of breast cancer metastases.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for minimally invasive surgeries is expected to grow at a CAGR of 6.8% from 2016 to 2021. This is primarily owing to the increasing preference for minimally invasive procedures over traditional open surgery procedures, due to their shorter recovery time and lesser surgical trauma. Liposomal drug-delivery systems offer an efficient and non-invasive means of delivering drugs directly to the site of action, making them an attractive option for use in minimally invasive surgeries.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as cancer, diabetes, and heart disease is on the rise globally due to changing lifestyles and aging populations. These diseases are often accompanied by severe symptoms that require long-term treatment with multiple drugs. This increases the need for safe and effective drug delivery systems that can target specific tissues or organs without causing any harm to healthy tissues nearby. Liposomal drug-delivery systems fulfill this need by providing a targeted means of delivering drugs directly to the affected tissue or organ while minimizing systemic exposure levels.
Scope Of The Report
Report Attributes
Report Details
Report Title
Liposomal Drug-delivery System Market Research Report
By Type
Liposome Vitamin, Liposome Ceramide, Liposome CoQ10, Others
By Application
Medical, Cosmetics
By Companies
Lipoid Kosmetik, Lucas Meyer Cosmetics, Nippon Fine Chemical, Enoc Solutions, Nanovec, Lipotec, Croda, H&A Pharmachem, Lipomize, ID bio, BioSpectrum, Derma Clinical, Kewpie Corporation, Nanohealth Biotech, Creative Biostructure, Phenbiox, NOF CORPORATION, KYOWA PHARMA CHEMICAL, Nikko Chemicals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
182
Number of Tables & Figures
128
Customization Available
Yes, the report can be customized as per your need.
Global Liposomal Drug-delivery System Market Report Segments:
The global Liposomal Drug-delivery System market is segmented on the basis of:
Types
Liposome Vitamin, Liposome Ceramide, Liposome CoQ10, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical, Cosmetics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lipoid Kosmetik
- Lucas Meyer Cosmetics
- Nippon Fine Chemical
- Enoc Solutions
- Nanovec
- Lipotec
- Croda
- H&A Pharmachem
- Lipomize
- ID bio
- BioSpectrum
- Derma Clinical
- Kewpie Corporation
- Nanohealth Biotech
- Creative Biostructure
- Phenbiox
- NOF CORPORATION
- KYOWA PHARMA CHEMICAL
- Nikko Chemicals
Highlights of The Liposomal Drug-delivery System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Liposome Vitamin
- Liposome Ceramide
- Liposome CoQ10
- Others
- By Application:
- Medical
- Cosmetics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Liposomal Drug-delivery System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A liposomal drug-delivery system is a type of drug delivery system that uses small, lipid-based vesicles to transport drugs and other therapeutic agents from the site of administration to target cells. Liposomes are formed from a variety of phospholipids, including cholesterol, and are composed of multiple water-soluble molecules that form bilayers. The hydrophobic core of the liposome contains the drug or agent, while the hydrophilic surface area allows for contact with surrounding tissues.
Some of the major companies in the liposomal drug-delivery system market are Lipoid Kosmetik, Lucas Meyer Cosmetics, Nippon Fine Chemical, Enoc Solutions, Nanovec, Lipotec, Croda, H&A Pharmachem, Lipomize, ID bio, BioSpectrum, Derma Clinical, Kewpie Corporation, Nanohealth Biotech, Creative Biostructure, Phenbiox, NOF CORPORATION, KYOWA PHARMA CHEMICAL, Nikko Chemicals.
The liposomal drug-delivery system market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Liposomal Drug-delivery System Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Liposomal Drug-delivery System Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Liposomal Drug-delivery System Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Liposomal Drug-delivery System Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Liposomal Drug-delivery System Market Size & Forecast, 2018-2028 4.5.1 Liposomal Drug-delivery System Market Size and Y-o-Y Growth 4.5.2 Liposomal Drug-delivery System Market Absolute $ Opportunity
Chapter 5 Global Liposomal Drug-delivery System Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Liposomal Drug-delivery System Market Size Forecast by Type
5.2.1 Liposome Vitamin
5.2.2 Liposome Ceramide
5.2.3 Liposome CoQ10
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Liposomal Drug-delivery System Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Liposomal Drug-delivery System Market Size Forecast by Applications
6.2.1 Medical
6.2.2 Cosmetics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Liposomal Drug-delivery System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Liposomal Drug-delivery System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Liposomal Drug-delivery System Analysis and Forecast
9.1 Introduction
9.2 North America Liposomal Drug-delivery System Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Liposomal Drug-delivery System Market Size Forecast by Type
9.6.1 Liposome Vitamin
9.6.2 Liposome Ceramide
9.6.3 Liposome CoQ10
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Liposomal Drug-delivery System Market Size Forecast by Applications
9.10.1 Medical
9.10.2 Cosmetics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Liposomal Drug-delivery System Analysis and Forecast
10.1 Introduction
10.2 Europe Liposomal Drug-delivery System Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Liposomal Drug-delivery System Market Size Forecast by Type
10.6.1 Liposome Vitamin
10.6.2 Liposome Ceramide
10.6.3 Liposome CoQ10
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Liposomal Drug-delivery System Market Size Forecast by Applications
10.10.1 Medical
10.10.2 Cosmetics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Liposomal Drug-delivery System Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Liposomal Drug-delivery System Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Liposomal Drug-delivery System Market Size Forecast by Type
11.6.1 Liposome Vitamin
11.6.2 Liposome Ceramide
11.6.3 Liposome CoQ10
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Liposomal Drug-delivery System Market Size Forecast by Applications
11.10.1 Medical
11.10.2 Cosmetics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Liposomal Drug-delivery System Analysis and Forecast
12.1 Introduction
12.2 Latin America Liposomal Drug-delivery System Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Liposomal Drug-delivery System Market Size Forecast by Type
12.6.1 Liposome Vitamin
12.6.2 Liposome Ceramide
12.6.3 Liposome CoQ10
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Liposomal Drug-delivery System Market Size Forecast by Applications
12.10.1 Medical
12.10.2 Cosmetics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Liposomal Drug-delivery System Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Liposomal Drug-delivery System Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Liposomal Drug-delivery System Market Size Forecast by Type
13.6.1 Liposome Vitamin
13.6.2 Liposome Ceramide
13.6.3 Liposome CoQ10
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Liposomal Drug-delivery System Market Size Forecast by Applications
13.10.1 Medical
13.10.2 Cosmetics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Liposomal Drug-delivery System Market: Competitive Dashboard
14.2 Global Liposomal Drug-delivery System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Lipoid Kosmetik
14.3.2 Lucas Meyer Cosmetics
14.3.3 Nippon Fine Chemical
14.3.4 Enoc Solutions
14.3.5 Nanovec
14.3.6 Lipotec
14.3.7 Croda
14.3.8 H&A Pharmachem
14.3.9 Lipomize
14.3.10 ID bio
14.3.11 BioSpectrum
14.3.12 Derma Clinical
14.3.13 Kewpie Corporation
14.3.14 Nanohealth Biotech
14.3.15 Creative Biostructure
14.3.16 Phenbiox
14.3.17 NOF CORPORATION
14.3.18 KYOWA PHARMA CHEMICAL
14.3.19 Nikko Chemicals